Your current location:Home > News > Industry News

Pharmaceutical companies actively promote intelligent manufacturing to further reduce costs and incr


Time:2024-12-24 16:29:02  Source:  Author:

 

In recent years, with the normalization of centralized procurement and the promotion of policies such as medical insurance cost control, pharmaceutical companies have generally faced pressure on their performance. How to reduce costs has become a problem that these companies have to face. Intelligent manufacturing, as a new production method that deeply integrates new generation information technology and advanced manufacturing technology, has become a trend actively embraced by pharmaceutical companies. More and more pharmaceutical companies are actively promoting intelligent manufacturing to further reduce costs and increase profits.

 
 
 
Recently, the "Get to Know My Listed Company - Entering Beijing Tianjin Hebei and Xinjiang" series of events, including the China Resources Double Crane Special Session, was successfully held. China Resources Shuanghe is a pharmaceutical company actively promoting intelligent manufacturing. Its solid preparation workshop has passed the new version of GMP certification. The production line design adopts one automated weighing line, four granulation lines, and nine packaging lines. With advanced design concepts and highly integrated automation equipment, it achieves modular, automated, digital batch production and multi variety flexible production, greatly improving production efficiency and steadily increasing gross profit margin due to cost reduction.
 
 
 
The Laiwu Intelligent Manufacturing Factory of Shandong Hongjitang Pharmaceutical Group has entered the formal production stage on September 29th this year. It is reported that since its launch in December 2023, the project has completed stability testing and GMP certification. After reaching full production capacity, it can achieve an annual output value of 10 billion yuan.
 
 
 
Yuekang Pharmaceutical continuously promotes technological innovation in production and quality management, implements intelligent manufacturing and green production, and achieves international integration of the drug production system. It is reported that since 2011, Yuekang Pharmaceutical has repeatedly passed the EU GMP certification, and certified products represented by omeprazole enteric coated capsules have entered the European market; In 2015, Guangzhou Pharmaceutical Factory passed the Japanese GMP certification.
 
 
 
Shangyao Xinyi has embarked on a "digital transformation" story in digital construction. After ten years, the company has completed the construction of MES projects for three varieties: Peifeikang, Ribavirin, and Metformin. It has implemented and deployed multiple core business systems, including MES (Manufacturing Execution System), ERP (Resource Planning System), SCADA (Data Acquisition System), LIMS (Laboratory Information Management System), PEMS (Power and Energy Management System), etc. It has organically integrated GMP (Good Manufacturing Practice) into the entire production management and achieved interconnection with hardware equipment such as elevated warehouses, robots, and production equipment.
 
 
 
Guizhou Sanli has designed and built a second phase factory based on the concept of "intelligent production and manufacturing of traditional Chinese medicine". The factory has brought the company's product process route, facilities and equipment, technical standards, and software management to the advanced level in China, enabling the company's core product production to achieve standardization, automation, and intelligence throughout the entire process, further improving product quality and production efficiency. It is reported that there are many core equipment and control links in the factory's spray intelligent production line, which is the first customized R&D in China and realizes intelligent manufacturing throughout the drug production process.
 
 
 
Under the trend of digitalization becoming an important lever for the transformation and upgrading of manufacturing enterprises, Northeast Pharmaceutical, an old pharmaceutical factory in Northeast China, is also accelerating its embrace of digitalization. The company extends the tentacles of digital transformation to various aspects of enterprise production, sales, safety, environmental protection, etc. in building closed-loop management. In the production process, Northeast Pharmaceutical applies modern technological means such as big data, cloud computing, and artificial intelligence to achieve digital management and intelligent control of the production process, realizing the transformation of pharmaceutical manufacturing to "smart manufacturing", thereby reducing costs and increasing efficiency, and ensuring the continuous stability of product quality.

Copyright © 2017-2020 SHANGHAI YINGRUI BIOPHARMA CO.,LTD 沪ICP备11038445号-1
TEL:+86-21-33585366(DDT)、34666753 FAX:+86-21-34979012
E-mail:info@shyrchem.com ADD:1885 Metropolitan Road, Minhang District, Shanghai Code:201108